This is in line with several reports on a negative prognostic role of p53 in GC and esophageal adenocarcinomas, although other studies did not find a correlation of altered p53 with survival in this tumor entity [9,11,14,19,20]. This evidence concerns the gene TP53 and gastric cancer.